Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel

Creative Commons License

Algul E., Sunman H., Dural M., Guliyev I., Aker M., Felekoglu M. A., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.49, sa.5, ss.1358-1365, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 5
  • Basım Tarihi: 2019
  • Doi Numarası: 10.3906/sag-1903-188
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1358-1365
  • Anahtar Kelimeler: Acute coronary syndrome, atrial fibrillation, ticagrelor, P-WAVE DISPERSION, PULMONARY VEIN ISOLATION, MYOCARDIAL-INFARCTION, ENDOGENOUS ADENOSINE, EUROPEAN-SOCIETY, CARDIOPROTECTION, ELEVATION, THERAPY, HEART, ONSET
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Background/aim: Ticagrelor is a drug widely used in patients with acute coronary syndromes (ACS) that specifically increases the plasma level of adenosine, which is likely to cause atrial fibrillation (AF). Therefore, in this study we aimed to investigate the electrocardiographic and echocardiographic predictors of AF development after P2Y12 receptor antagonists in ACS patients.